Avnet, Inc., distributes electronic component technology. The company operates through two segments, Electronic Components and Farnell. The Electronic Components segment markets, sells, and distributes semiconductors; interconnect, passive, and electromechanical components; and other integrated components from electronic component manufacturers. It also offers design chain support that provides engineers with technical design solutions; engineering and technical resources to support product design, bill of materials development, and technical education and training; and supply chain solutions that provide support, warehousing, and logistical services to original equipment manufacturers, electronic manufacturing service providers, and electronic component manufacturers. In addition, this segment provides embedded solutions, such as technical design, integration, and assembly of embedded products, systems, and solutions, as well as embedded display solutions comprising touch and passive displays; and develops and manufactures standard board and industrial subsystems, and application-specific devices that enable it to produce systems tailored to specific customer requirements. This segment serves various markets, such as automotive, medical, defense, aerospace, telecommunications, industrial, and digital editing. The Farnell segment distributes kits, tools, and electronic and industrial automation components, as well as test and measurement products to engineers and entrepreneurs. It has operations in the Americas, Europe, the Middle East, Africa, and Asia. Avnet, Inc. was founded in 1921 and is headquartered in Phoenix, Arizona.

Avnet Inc.

Analysts are intrested in these 5 stocks: ( ($KTOS) ), ( ($AMD) ), ( ($CCEP) ), ( ($AVTX) ) and ( ($WSM) ). Here is a breakdown of their recent


Kratos, AMD, CCEP, Avalo, WSM Trending With Analysts

Avalo Therapeutics ( ($AVTX) ) has provided an update. On June 11, 2026, Avalo Therapeutics entered into an exchange agreement with an accredited i...

Avalo Therapeutics Expands Ownership Limits, Updates Executive Contracts

Avalo Therapeutics ( ($AVTX) ) has provided an announcement. At its annual meeting held on June 2, 2026, Avalo Therapeutics stockholders elected se...

Avalo Therapeutics Shareholders Back Directors and Governance Changes

Guotai Haitong analyst maintained a Buy rating on AviChina Industry & Technology Co on May 27 and set a price target of HK$4.48. The company’s shar...

Current Quarter	$1.76	Next Quarter	$1.66
Current Year	$5.12	Next Year	$7.3
QoQ Growth	-5.7%	YoY Growth	+42.6%
3Y EPS CAGR	-26.6%	Target Price	$89.00
Consensus	Buy	Upside	+0.9%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AVT	$88.24	-1.52%	2.04M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AVT	$88.24	-1.5%	2.04M
3
4
5
6

AVT

AVT

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Avnet Inc. Data in Excel

Get Avnet Inc. Data in Excel